These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 28746799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C, Pandit H, Nagy BA, Stellas D, Jensen SM, Bear J, Cam M, Valentin A, Fox BA, Felber BK, Pavlakis GN.
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
    Wang D, Jiang W, Zhu F, Mao X, Agrawal S.
    Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z, Wang H, Meng F, Li J, Zhang S.
    J Transl Med; 2015 Jul 29; 13():247. PubMed ID: 26219551
    [Abstract] [Full Text] [Related]

  • 8. TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
    Case K, Tran L, Yang M, Zheng H, Kuhtreiber WM, Faustman DL.
    J Leukoc Biol; 2020 Jun 29; 107(6):981-991. PubMed ID: 32449229
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
    Marshall NA, Galvin KC, Corcoran AM, Boon L, Higgs R, Mills KH.
    Cancer Res; 2012 Feb 01; 72(3):581-91. PubMed ID: 22158905
    [Abstract] [Full Text] [Related]

  • 12. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K, Arii S, Yamasaki S, Mizumoto M, Mori A, Inoue N, Isobe N, Imamura M.
    Int J Cancer; 2000 Sep 01; 87(5):665-72. PubMed ID: 10925360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity.
    Onda M, Kobayashi K, Pastan I.
    Proc Natl Acad Sci U S A; 2019 Mar 05; 116(10):4575-4582. PubMed ID: 30760587
    [Abstract] [Full Text] [Related]

  • 15. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
    Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV.
    J Surg Res; 2021 Jul 05; 263():44-52. PubMed ID: 33631377
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.
    Kitamura H, Ohno Y, Toyoshima Y, Ohtake J, Homma S, Kawamura H, Takahashi N, Taketomi A.
    Cancer Sci; 2017 Oct 05; 108(10):1947-1952. PubMed ID: 28749573
    [Abstract] [Full Text] [Related]

  • 17. Potent antitumor activity of interleukin-27.
    Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y, Mizuguchi J, Yoshimoto T.
    Cancer Res; 2004 Feb 01; 64(3):1152-6. PubMed ID: 14871851
    [Abstract] [Full Text] [Related]

  • 18. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL, Zheng Z, Li BD, Xie SJ, Li GX, Yan QH, Cai JH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov 01; 23(11):1046-9. PubMed ID: 17988589
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.